Francis, D L <br/><br/>
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.  [electronic resource] 

 -  European journal of nuclear medicine and molecular imaging  Jul 2003 
 - 988-94 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1619-7070 
<br/><br/><label>Standard No.: </label>10.1007/s00259-003-1187-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Colorectal Neoplasms--diagnostic imaging<br/>Dideoxynucleosides<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Male<br/>Middle Aged<br/>Radiopharmaceuticals<br/>Reproducibility of Results<br/>Sensitivity and Specificity<br/>Tomography, Emission-Computed--methods<br/>Whole-Body Counting